Domainex

Domainex
Drug discovery services company specializing in small molecule drug discovery and medicinal chemistry.
About
What does Domainex do?
Domainex is a drug discovery services company that drives discovery and delivers leads for pharmaceutical and biotechnology partners. They offer integrated drug discovery solutions, encompassing biosciences and chemistry services, to advance drug development programs. Their expertise spans hit identification, lead optimization, and a range of specialized assays and technologies.
Where is Domainex headquartered?
Domainex is headquartered in Cambridge, United Kingdom.
When was Domainex founded?
Domainex was founded in 2001.
What industry does Domainex operate in?
Domainex operates in Biotech, Drug Discovery, Medicinal Chemistry, Contract Research Organization, Pharmaceutical Services, HealthTech.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.